Amryt Pharma plc reaffirmed revenue guidance for fiscal year 2022. For the year, the company is reaffirming revenue guidance for fiscal year 2022 in the range of $260 million - $270 million which represents growth of 17% to 21% on fiscal year 2021.
1st Jan change | Capi. | |
---|---|---|
-0.07% | 89.46B | |
+2.76% | 40.74B | |
-9.06% | 33.03B | |
+55.32% | 24.68B | |
-16.61% | 15.12B | |
-9.14% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |